Healthtech Startups

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.

1 investor

ExMedio provides an IT platform called Hipokura that enables physicians across specialties to share clinical knowledge, seek specialist consultations, and discuss cases to improve diagnostic and treatment quality. The platform serves doctors in Japan with over 70,000 registered physicians and includes specialized consultation features for dermatology, ophthalmology, cardiology, pulmonology, and rare diseases.

1 investor

Company positioned around injury care technology, with details pending a forthcoming website launch.

1 investor

Exogenus develops therapeutic exosomes derived from umbilical cord blood cells to treat autoimmune diseases through immune system rebalancing. The company targets multiple autoimmune disease indications where existing pharmaceutical treatments carry significant side effects.

1 investor

Exonic develops machine learning models trained on biological data to predict gene therapy designs and genomic regulatory patterns, with initial applications in developing targeted treatments for liver cancer.

1 investor

Exosomm is a biotechnology company that extracts and standardizes bioactive milk exosomes into commercial ingredients for advanced nutrition and supplement brands. The company licenses these bioactive compounds as a differentiated platform for premium health and wellness products.

1 investor

1 investor

Expedition Therapeutics is a drug development company focused on advancing therapeutic programs in areas such as CAR-T immunotherapy and oncology. The company serves patients and healthcare systems seeking novel treatment options.

1 investor

Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services. The company provides process development, analytical testing, technology transfer, and scale-up support for inhalation drugs and encapsulated solid dose pharmaceuticals.

1 investor

Experity offers an AI-driven software platform for urgent care businesses, connecting clinical, front desk, and billing workflows across the patient journey. Its products cover EMR and practice management, patient engagement, revenue cycle management, and teleradiology/imaging services.

1 investor

EXPIN develops AI-driven tools for clinicians to analyze exposome data—the lifetime accumulation of environmental, chemical, and lifestyle exposures—to enable precision medicine for chronic disease prevention and treatment. The company serves healthcare providers and patients seeking to understand how non-genetic factors drive disease at the molecular level.

1 investor

ExpiWell provides ecological momentary assessment (EMA) and experience sampling (ESM) software used by researchers to capture real-time data on participants' daily experiences, emotions, and behaviors. The platform enables peer-reviewed research across psychology, medicine, organizational behavior, and ESM methodology.

1 investor

ExploraMed is a medical device incubator that develops new med tech companies and products from early-stage concept through development. Its portfolio includes ventures such as Revelle Aesthetics, an aesthetics medical device company acquired by Tiger Aesthetics in 2024.

1 investor

Exposome researches how environmental factors affect human health and develops products through its formulations and application lab, supported by its own manufacturing facility. The company operates in the health and wellness space with in-house product development and production.

1 investor

Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility. The company serves families seeking speech-language pathology care for their children.

1 investor

Express Healthcare is an Indian news and media publication covering the healthcare industry, including hospitals, medical devices, pharma, and health startups. It publishes news, interviews, and analysis for healthcare professionals and industry stakeholders in India.

1 investor

Exubrion Therapeutics develops veterinary therapies using conversion electron therapy from Tin-117m to treat pain and inflammation in companion animals. Its initial product, Synovetin OA, is a minimally invasive intra-articular injection for canine elbow osteoarthritis, marketed to veterinarians and pet owners.

1 investor

Exxat provides a platform for managing clinical and experiential education, including curriculum, fieldwork assessments, competency-based education, credentialing, placement coordination, and accreditation. It serves academic institutions across health, allied, and behavioral sciences such as nursing, physical therapy, social work, counseling, and physician assistant programs, using AI-powered insights on student, site, and scheduling data.</parameter> <parameter name="founders">[]

1 investor

Eye to Eye Telehealth develops technology to address data gaps in glaucoma care, working with engineers and clinicians to improve monitoring and treatment. It focuses on telehealth solutions for glaucoma management.

1 investor

Eyebot provides automated eyeglass prescription services using AI technology, enabling customers to receive doctor-written prescriptions in minutes without traditional eye exams. The company targets optical retailers and healthcare providers seeking to increase patient throughput and improve vision care accessibility.

1 investor

EyeBuddy develops AI tools for early detection of eye diseases that work alongside clinicians in hospitals and eye care facilities. The company serves ophthalmologists and healthcare providers in Canada, South Asia, and the UK, with a focus on making eye care accessible to underserved populations.

1 investor

EyeCare Partners operates a network of over 1,000 eye care providers across the United States, offering a full continuum of vision care services including ophthalmology and optometry. The doctor-led organization combines individual practice autonomy with centralized resources to improve patient outcomes and accessibility.

1 investor

EyeCheck develops vision screening tools to identify refractive errors and expand access to eye care for underserved populations globally.

1 investor

CHV is a venture capital firm that invests in medical technology companies developing therapeutic devices, diagnostic tools, and digital health solutions to improve patient outcomes.

1 investor